Diseases Market Research Reports

Medical Diseases Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
Common Disease Treatment Drugs Markets in China (13 Full Research Reports Collection)

Common Disease Treatment Drugs Markets in China (13 Full Research Reports Collection)

Date Published: Jan 15 2014

China's demand for common disease treatment drugs markets has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This is a collection of 13 full market research reports:

$12,000.00
Global Procedures for Fractures and Degenerative Disc Disease

Global Procedures for Fractures and Degenerative Disc Disease

Date Published: Jan 1 2014
This report pertains to a forecast period of 10 years (2009 – 2019) for North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including Germany, Frange, the U.K., Italy, Spain, Belgium, the Netherlands, Denmark, Finland, Norway, Sweden, Austria, Switzerland and Portugal.
 
Reasons To Buy
 
$10,995.00
PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

Date Published: Apr 30 2013

PharmaPoint: Multiple Sclerosis - Global Drug Forecast and Market Analysis to 2022 Event-Driven Update

Summary

$9,995.00
PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

Date Published: Dec 31 2013
PharmaPoint: Microvascular Complications of Diabetes Global Drug Forecast and Market Analysis to 2022
 
$9,995.00
PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Dry Eye Syndrome - Global Drug Forecast and Market Analysis to 2022

Summary

The Dry Eye Syndrome (DES) pipeline is strong, with 49 molecules in various phases of development. More notably, the late-stage pipeline has three products with novel mechanisms of action to treat the inflammation associated with the disease. That said, physicians suggest that the largest unmet need for DES treatment is diagnosis.

Highlights

Key Questions Answered

$9,995.00
PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

Date Published: Nov 30 2013

PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

Date Published: May 31 2013

PharmaPoint: Psoriasis - Global Drug Forecast and Market Analysis to 2022

Summary

There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective, these therapies are still lacking because of their immunosuppressant nature and lack of understanding as to their exact mechanism of action.

Highlights

Key Questions Answered

$9,995.00
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2014
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines Global Drug Forecast and Market Analysis to 2022
 
$9,995.00
PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022

Date Published: Jun 30 2013

PharmaPoint: Chronic Heart Failure - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Type 2 Diabetes - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

Date Published: Jan 31 2014
$9,995.00
PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

Date Published: Jan 31 2013

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

Summary

$9,995.00
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

Date Published: Jun 30 2013

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Crohn’s Disease - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2014
The Crohn’s disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as - 
  • Takeda’s alpha4beta7 inhibitor, Entyvio (vedolizumab)
  • Johnson & Johnson’s (J&J’s) interleukin (IL)-12/23 inhibitor, Stelara (ustekinumab)
 
$9,995.00
PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022

Date Published: Jan 31 2013

PharmaPoint: Osteoporosis - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2022

Date Published: Jul 31 2013

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2022

Summary

There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease.

Highlights

Key Questions Answered

$9,995.00
PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

Date Published: Jul 31 2013

PharmaPoint: Postmenopausal Vaginal Atrophy - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

Date Published: Oct 31 2013

PharmaPoint: Obesity - Global Drug Forecast and Market Analysis to 2022

Summary

$9,995.00
PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

Date Published: Feb 27 2013

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis Event-Driven Update

Summary

$9,995.00

Pages

Shopping cart

0 Items $0.00
Market Research Special Offers
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianB. Braun, Cobham, fiserv, Harris, Wipro, AonMunich Re, Lotte Chemical, National Post, First Data